ИСТИНА

Curreli Francesca

Соавторы: Altieri A., Debnath A.K., Куркин А.В., Белов Д.С., Юсупов И.Р., Ahmed S., Спиридонов Е.А., Kwong P.D., Манасова Е.В., Марков П.О., Arnold E., Burgos G., Das K. показать полностью..., Drelich A., Furimsky A.M., Gruber K., Hillyer C.D., Horrigan S., Kwon Y.D., Losada N., Nicolau I., O'Loughlin K., Panda S.S., Pilch A., Ruiz F.X., Stoddart C.A., Tseng C.K., Verardi R., Белов Д.С., Розенталь В.А.

13 статей

Количество цитирований статей в журналах по данным Web of Science: 102, Scopus: 126

IstinaResearcherID (IRID): 347926167

Деятельность

• Статьи в журналах

  • • 2022 Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists
    • Curreli Francesca, Kwon Young D., Nicolau Isabella, Burgos Giancarla, Altieri Andrea, Kurkin Alexander V., Verardi Raffaello, Kwong Peter D., Debnath Asim K.
    • в журнале International Journal of Molecular Sciences, издательство MDPI (Basel, Switzerland), том 23, № 24, с. 15999 DOI
  • • 2022 Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model
    • Stoddart Cheryl A., Curreli Francesca, Horrigan Stephen, Altieri Andrea, Kurkin Alexander V., Debnath Asim K.
    • в журнале Viruses, издательство MDPI (Basel, Switzerland) DOI
  • • 2022 Design, Synthesis, and Antiviral Activity of the Thiazole Positional Isomers of a Potent HIV-1 Entry Inhibitor NBD-14270
    • Kurkin Alexander V., Curreli Francesca, Iusupov Ildar R., Spiridonov Evgeniy A., Ahmed Shahad, Markov Pavel O., Manasova Ekaterina V., Altieri Andrea, Debnath Asim K.
    • в журнале ChemMedChem, издательство Wiley - V C H Verlag GmbbH & Co. (Germany) DOI
  • 
    • 2022 Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays
    • Curreli Francesca, Ahmed Shahad, Victor Sofia M.B., Drelich Aleksandra, Panda Siva S., Altieri Andrea, Kurkin Alexander V., Tseng Chien-Te K., Hillyer Christopher D., Debnath Asim K.
    • в журнале Viruses, издательство MDPI (Basel, Switzerland), том 14, № 1, с. 69 DOI
  • 
    • 2021 Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements
    • Iusupov Ildar R., Curreli Francesca, Spiridonov Evgeniy A., Markov Pavel O., Ahmed Shahad, Belov Dmitry S., Manasova Ekaterina V., Altieri Andrea, Kurkin Alexander V., Debnath Asim K.
    • в журнале European Journal of Medicinal Chemistry, издательство Elsevier BV (Netherlands), том 224 DOI
  • 
    • 2021 Design, Synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors
    • Curreli F., Ahmed S., Benedict Victor S.M., Iusupov I.R., Spiridonov E.A., Belov D.S., Altieri A., Kurkin A.V., Debnath A.K.
    • в журнале Bioorganic and Medicinal Chemistry, издательство Pergamon Press Ltd. (United Kingdom), том 32, с. 116000 DOI
  • • 2021 HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites
    • Losada Natalie, Ruiz Francesc X., Curreli Francesca, Gruber Kevin, Pilch Alyssa, Altieri Andrea, Kurkin Alexander V., Das Kalyan, Debnath Asim K., Arnold Eddy
    • в журнале Journal of Medicinal Chemistry, издательство American Chemical Society (United States), том 64, № 22, с. 16530-16540 DOI
  • 
    • 2020 Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral Evaluation
    • Curreli F., Shahad A., Benedict Victor S.M., Iusupov I.R., Belov D.S., Markov P.O., Kurkin A.V., Altieri A., Debnath A.K.
    • в журнале Journal of Medicinal Chemistry, издательство American Chemical Society (United States), том 63, № 4, с. 1724-1749 DOI
  • 
    • 2018 Guanidine-containing phenyl-pyrrole compounds as probes for generating HIV entry inhibitors targeted to gp120
    • Belov D.S., Curreli F., Kurkin A.V., Altieri A., Debnath A.K.
    • в журнале ChemistrySelect, том 3, № 23, с. 6450-6453 DOI
  • 
    • 2018 Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120
    • Curreli F., Belov D.S., Kwon Y.D., Ranjith R., Furimsky A.M., O'Loughlin K., Byrge P.C., Iyer L.V., Mirsalis J.C., Kurkin A.V., Altieri A., Debnath A.K.
    • в журнале European Journal of Medicinal Chemistry, издательство Elsevier BV (Netherlands), том 154, с. 367-391 DOI
  • 
    • 2018 Synthesis, antiviral activity, and structure‐activity relationship of 1,3‐benzodioxolyl pyrrole‐based entry inhibitors targeting the Phenyl43 cavity in HIV‐1 gp120
    • Debnath A.K., Curreli F., Belov D.S., Ahmed S., Ramesh R.R., Kurkin A.V., Altieri A.
    • в журнале ChemMedChem, издательство Wiley - V C H Verlag GmbbH & Co. (Germany), том 13, № 21, с. 2332-2348 DOI
  • 
    • 2017 Synthesis, antiviral potency, in vitro ADMET and X-ray structure of potent CD4-mimics as entry inhibitors that target the Phe43 cavity of HIV-1 gp120
    • Curreli F., Kwon Y.D., Belov D.S., Ramesh R.R., Kurkin A.V., Altieri A., Kwong P.D., Debnath A.K.
    • в журнале Journal of Medicinal Chemistry, издательство American Chemical Society (United States), том 60, № 7, с. 3124-3153 DOI
  • 
    • 2016 Design, synthesis and evaluation of small molecule CD4-mimics as entry inhibitors possessing broad spectrum anti-HIV-1 activity
    • Curreli F., Belov D.S., Ranjith R.R., Patel N., Altieri A., Kurkin A.V., Debnath A.K.
    • в журнале Bioorganic and Medicinal Chemistry, издательство Pergamon Press Ltd. (United Kingdom), том 24, № 22, с. 5988-6003 DOI